Cypralis Limited
🏢 View company profile →6Patents
6Active
6Granted
43Portfolio score
Filing activity: Oct 2, 2013 → Sep 25, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9873716B2 | Macrocyclic inhibitors of flaviviridae viruses | Emerging Cross-Sectional Technologies | 2 | Active |
| US10472392B2 | Macrocyclic inhibitors of flaviviridae viruses | Emerging Cross-Sectional Technologies | 0 | Active |
| US10246486B2 | Macrocyclic inhibitors of flaviviridae viruses | Emerging Cross-Sectional Technologies | 0 | Active |
| USRE47334E1 | Macrocyclic inhibitors of flaviviridae viruses | General | 0 | Active |
| US9895412B2 | Cyclic depsipeptide compounds and their uses | Human Necessities | 0 | Active |
| US9382295B2 | Cyclic depsipeptide compounds and their uses | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.